Optimal management of cytomegalovirus retinitis in patients with AIDS

References

• KedharSRJabsDACytomegalovirus retinitis in the era of highly active antiretroviral therapyHerpes200714667118371289
   PubMedGoogle Scholar
• StarasSASDollardSCRadfordKWSeroprevalence of cytomegalovirus infection in the United States, 1988–1994Clin Infect Dis2006431143115117029132
   PubMed Web of Science ®Google Scholar
• DrewWLMitzLMinerRCPrevalence of cytomegalovirus infection in homosexual malesJ Infect Dis19811431881926260871
   PubMed Web of Science ®Google Scholar
• GallantJEMooreRDRichmanDDIncidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study GroupJ Infect Dis1992166122312271358986
   PubMed Web of Science ®Google Scholar
• GottliebMSSchroffRSchankerHMPneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiencyN Engl J Med1981305142514316272109
   PubMed Web of Science ®Google Scholar
• MasurHMichelisMAGreeneJBAn outbreak of community-acquired Pneumocystis carinii pneumonia: Initial manifestation of cellular immune dysfunctionN Engl J Med1981305143114386975437
   PubMed Web of Science ®Google Scholar
• HollandGNGottliebMSYeeRDOcular disorders associated with a new severe acquired cellular immunodeficiency syndromeAm J Ophthalmol1982933934026280503
   PubMed Web of Science ®Google Scholar
• HollandGNBuhlesWCMastreBKaplanHJA controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy Study GroupArch Ophthalmol1989107175917662556989
   PubMed Web of Science ®Google Scholar
• Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials GroupFoscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosisAm J Ophthalmol19971241411579262538
   PubMed Web of Science ®Google Scholar
• BloomJNPalestineAGThe diagnosis of cytomegalovirus retinitisAnn Intern Med19881099639692848436
   PubMed Web of Science ®Google Scholar
• KuppermanBDPettyJGRichmanDDCorrelation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndromeAm J Ophthalmol19931155755828098183
   PubMed Web of Science ®Google Scholar
• PertelPHirschtickREPhairJRisk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virusJ Acquir Immune Defic Syndr19925106910741357151
   PubMed Web of Science ®Google Scholar
• Definition of HAART Available from: http://statepiaps.jhsph.edu/wihs/Invest-info/Def-haart.pdfAccessed on January 10, 2010
   Google Scholar
• SkiestDJCytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART)Am J Med Sci199931731833510334120
   PubMed Web of Science ®Google Scholar
• JabsDAVan NattaMLHolbrookJTLongitudinal study of the ocular complications of AIDS. 1. Ocular diagnoses at enrollmentOphthalmology200711478078617258320
   PubMed Web of Science ®Google Scholar
• JabsDAVan NattaMLHolbrookJTLongitudinal study of the ocular complications of AIDS. 2. Ocular examination results at enrollmentOphthalmology200711478779317210182
   PubMed Web of Science ®Google Scholar
• HollandGNVaudauxJDShiramizuKMCharacteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000)Am J Ophthalmol2008145122218154751
   PubMed Web of Science ®Google Scholar
• JabsDAvan NattaMLKempenJHCharacteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapyAm J Ophthalmol2002133486111755839
   PubMed Web of Science ®Google Scholar
• JabsDAvan NattaMLThorneJECourse of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachmentOphthalmology20041112232223915582079
   PubMed Web of Science ®Google Scholar
• JabsDAvan NattaMLThorneJECourse of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progressionOphthalmology20041112224223115582078
   PubMed Web of Science ®Google Scholar
• JabsDAHolbrookJTvan NattaMLRisk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapyOphthalmology200511277177915878056
   PubMed Web of Science ®Google Scholar
• LalezariJPFriedbergDNBissetJHigh dose oral ganciclovir treatment for cytomegalovirus retinitisJ Clin Virol200224677711744430
   PubMed Web of Science ®Google Scholar
• NobleSFauldsDGanciclovir: An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipientsDrugs1998561151469664203
   PubMed Web of Science ®Google Scholar
• FauldsDHeelRCGanciclovir: A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infectionsDrugs1990395976382161731
   PubMed Web of Science ®Google Scholar
• MarkhamAFauldsDGanciclovir: An update of its therapeutic use in cytomegalovirus infectionDrugs1994484554847527763
   PubMed Web of Science ®Google Scholar
• BoivinGGilbertCGaudreauARate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitisJ Infect Dis20011841598160211740736
   PubMed Web of Science ®Google Scholar
• JabsDAMartinBKFormanMSCytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitisAm J Ophthalmol2003135263412504693
   PubMed Web of Science ®Google Scholar
• BironKKAntiviral drugs for cytomegalovirus diseasesAntiviral Res20067115416316765457
   PubMed Web of Science ®Google Scholar
• RazonableRREmeryVCManagement of CMV infection and disease in transplant patients [Consensus article IHMF management recommendations]Herpes200411778615960905
   PubMedGoogle Scholar
• De ClerqEAntiviral drugs in current clinical useJ Clin Virol20043011513315125867
   PubMed Web of Science ®Google Scholar
• DrewWLIvesDLalezariJPOral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDSN Engl J Med19953336156207637721
   PubMed Web of Science ®Google Scholar
• MartinDFKuppermanBDWolitzRAOral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implantN Engl J Med19993401063107010194235
   PubMed Web of Science ®Google Scholar
• BrownFBankenLSaywellKPharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteersClin Pharmacokinet19993716717610496303
   PubMed Web of Science ®Google Scholar
• JungDDorrASingle-dose pharmacokinetics of valganciclovir in HIV-and CMV-seropositive subjectsJ Clin Pharmacol19993980080410434231
   PubMed Web of Science ®Google Scholar
• HenryKCantrillHFletcherCUse of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDSAm J Ophthalmol198710317233026186
   PubMed Web of Science ®Google Scholar
• YoungSHMorletNHenrySHigh dose intravitreal ganciclovir in the treatment of cytomegalovirus retinitisMed J Aust19921573703731333036
   PubMed Web of Science ®Google Scholar
• Cochereau-MassinILehoangPLautier-FrauMEfficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndromeOphthalmology199198134813531658703
   PubMed Web of Science ®Google Scholar
• Diaz-LlopisMChipontESanchezIntravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndromeAm J Ophthalmol19921147427471334376
   PubMed Web of Science ®Google Scholar
• LiebermanRMOrellanaJMeltonRCEfficacy of intravitreous foscarnet in a patient with AIDSN Engl J Med20043308688698114855
   PubMed Web of Science ®Google Scholar
• Diaz-LlopisMEspanaEMunozGHigh dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDSBr J Ophthalmol1994781201248123619
   PubMed Web of Science ®Google Scholar
• Package insert. Vistide (cidofovir, Foster City, CA: Gilead Sciences, September 1996).
   Google Scholar
• RahhalFMArevaloJFMunguiaDIntravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitisOphthalmology1996103107810838684797
   PubMed Web of Science ®Google Scholar
• KuppermanBWolitzRStaggRA Phase II randomized, double-masked study of intraocular cidofovir for relapsing cytomegalovirus retinitis in patients with AIDS [Abstract]Presented at the Vitreous Society Annual MeetingCancun, MexicoDecember 8–12, 1996
   Google Scholar
• JabsDAOcular manifestations of HIV infectionTrans Am Ophthalmol Soc1995936236838719695
   PubMedGoogle Scholar
• KempenJHJabsDAWilsonLAIncidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitisAm J Ophthalmol20051391028103415953432
   PubMed Web of Science ®Google Scholar
• KempenJHJabsDAWilsonLAMortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndromeClin Infect Dis2003371365137314583871
   PubMed Web of Science ®Google Scholar
• JabsDAHolbrookJTvan NattaMLRisk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapyOphthalmology200511277177915878056
   PubMed Web of Science ®Google Scholar
• MuschDCMartinDFGordonJFTreatment of cytomegalovirus retinitis with a sustained-release ganciclovir implantN Engl J Med199733783909211677
   PubMed Web of Science ®Google Scholar
• CvetkovicRSWellingtonKValganciclovir: A review of its use in the management of CMV infection and disease in immunocompromised patientsDrugs20056585987815819597
   PubMed Web of Science ®Google Scholar
• The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials GroupCombination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: The Cytomegalovirus retreatment trialArch Ophthalmol199611423338540847
   PubMedGoogle Scholar
• JacobsonMADrug therapy: treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndromeN Engl J Med19973371051149211681
   PubMed Web of Science ®Google Scholar
• The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials GroupThe ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The ganciclovir cidofovir cytomegalovirus retinitis trialAm J Ophthalmol200113145746711292409
   PubMed Web of Science ®Google Scholar
• KuppermanBDQuicenoJIFlores-AguilarMIntravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapyJ Infect Dis1993168150615098245536
   PubMed Web of Science ®Google Scholar
• AraveloJFGonzalezCCapparelliEVIntravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitisJ Infect Dis19951729519567561215
   PubMed Web of Science ®Google Scholar
• JabsDAEngerCDunnJPFormanMCytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study GroupJ Infect Dis19981777707739498461
   PubMed Web of Science ®Google Scholar
• JabsDAEngerCDunnJPFormanMIncidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study GroupAntimicrob Agents Chemother199842224022449736542
   PubMed Web of Science ®Google Scholar
• WeinbergAJabsDAChouSMutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitisJ Infect Dis200318777778412599051
   PubMed Web of Science ®Google Scholar
• MartinDFSierra-MaderoJWalmsleySA controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitisN Engl J Med20023461119112611948271
   PubMed Web of Science ®Google Scholar
• PloskerGLNobleSCidofovir: A review of its use in cytomegalovirus retinitis in patients with AIDSDrugs19995832534510473024
   PubMed Web of Science ®Google Scholar
• WalmsleySTsengAComparative tolerability of therapies for cytomegalovirus therapyDrug Saf19992120322410487398
   PubMed Web of Science ®Google Scholar
• AcharyaNYoungLSustained-release drug implants for the treatment of intraocular diseaseInt Ophthalmol Clin200444333915211175
   PubMedGoogle Scholar
• JabsDAAIDS and Ophthalmology, 2008Arch Ophthalmol20081261143114618695113
   PubMedGoogle Scholar
• MahadeviaPJGeboKAPettitKThe epidemiology, treatment patterns, and costs of cytomegalovirus retinitis in the post-HAART era among a national managed-care populationJ Acquir Immune Defic Syndr20043697297715220705
   PubMed Web of Science ®Google Scholar
• WalmsleySLRaboudJAngelJBLong-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitisHIV Clin Trials200671916632459
   PubMed Web of Science ®Google Scholar
• MartinBKRicksMOFormanMSJabsDAChange over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitisClin Infect Dis2007441001100817342657
   PubMed Web of Science ®Google Scholar
• BensonCAKaplanJEMasurHTreating opportunistic infections among HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of AmericaMMWR Recomm Rep200453111215841069
   PubMedGoogle Scholar
• HollandGNDiscussion of MacDonald JC, Karavellas MP, Torriani FJ, et al. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitisOphthalmology200010787783310811078
   PubMed Web of Science ®Google Scholar
• WohlDAKendallMAOwensSThe safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapyHIV Clin Trials2005613614616192248
   PubMed Web of Science ®Google Scholar
• JabsDAMartinBKFormanMSRicksMOCytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitisJ Infect Dis200519264064916028133
   PubMed Web of Science ®Google Scholar
• HollandGNAIDS and Ophthalmology: The first quarter centuryAm J Ophthalmol200814539740818282490
   PubMed Web of Science ®Google Scholar
• SkiestDJCytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART)Am J Med Sci199931731833510334120
   PubMed Web of Science ®Google Scholar
• KempenJHFrickKDJabsDAIncremental cost effectiveness of prophylaxis for cytomegalovirus disease in patients with AIDSPharmacoeconnomics20011911991208
   Web of Science ®Google Scholar
• MurdochDMVenterWDVan RieAFeldmanCImmune reconstitution inflammatory syndrome (IRIS): Review of common infectious manifestations and treatment optionsAIDS Research and Therapy20074917488505
   PubMedGoogle Scholar
• KempenJHMinYIFreemanWRRisk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitisOphthalmology200611368469416581429
   PubMed Web of Science ®Google Scholar
• HirschHHKaufmannGSendiPImmune reconstitution in HIV infected patientsClin Infect Dis2004381159116615095223
   PubMed Web of Science ®Google Scholar
• ThorneJEJabsDAKempenJHIncidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapyOphthalmology200611314231440
   Web of Science ®Google Scholar
• FrenchMAThe immunopathogenesis of mycobacterial immune restoration diseaseLancet Infect Dis2006646146216870523
   PubMed Web of Science ®Google Scholar
• KaravellasMPPlummerDJMacDonaldJCIncidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapyJ Infectious Dis19991796977009952380
   PubMed Web of Science ®Google Scholar
• KempenJHMinYIFreemanWRRisk of immunity recovery uveitis in patients with AIDS and cytomegalovirus retinitisOphthalmology200611368469416581429
   PubMed Web of Science ®Google Scholar
• SchrierRDSongMKSmithILIntraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitisRetina20062616516916467672
   PubMed Web of Science ®Google Scholar
• WestenegACRothovaADe BoerJHGroot-MijnesJDInfectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysisAm J Ophthalmol200714478178517707328
   PubMed Web of Science ®Google Scholar
• Ortega-LarroceaGEspinosaEReyes-TeranGLower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapyAIDS20051973573815821403
   PubMed Web of Science ®Google Scholar
• HendersonHWMitchellSMTreatment of immune recovery vitritis with local steroidsBr J Ophthalmol19998354054510216051
   PubMed Web of Science ®Google Scholar
• KaravellasMPAzenSPMacdonaldCImmune recovery uveitis and uveitis in AIDS: Clinical predictors, sequellae and treatment outcomeRetina2001211911217922
   PubMed Web of Science ®Google Scholar
• El-BradeyMChengLSongMLong term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approachRetina20042437638215187659
   PubMed Web of Science ®Google Scholar
• HendersonHWMitchellSMTreatment of immune recovery vitritis with local steroidsBr J Ophthalmol19998354054510216051
   PubMed Web of Science ®Google Scholar
• RothovaAInflammatory cystoid macular oedemaCurrent Opinion Ophthalmol200718487492
   PubMed Web of Science ®Google Scholar
• Ufret-VincentyRLSinghRPLowderCYKaiserPKCytomegalovirus retinitis after fluocinolone acetonide implantAm J Ophthalmol200714333433517258523
   PubMed Web of Science ®Google Scholar
• MorrisonVLKozakILaBreeLDIntravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edemaOphthalmology200711433433917270681
   PubMed Web of Science ®Google Scholar
• CanzanoJCMorseLSWendelRTSurgical repair of cytomegalovirus-related retinal detachment without silicone oil in patients with AIDSRetina19991927428010458290
   PubMed Web of Science ®Google Scholar
• DavisJRemoving silicone oil from eyes with cytomegalovirus retinitisAm J Ophthalmol200514090090216310469
   PubMed Web of Science ®Google Scholar
• KestelynPThe epidemiology of CMV retinitis in AfricaOcul Immunol Inflamm1999717317710611725
   PubMed Web of Science ®Google Scholar
• ShahSUKerkarSPPazareAREvaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western IndiaBr J Ophthalmol200993889018952644
   PubMed Web of Science ®Google Scholar
• GharaiSVenkateshPGargSOphthalmic manifestations of HIV infections in India in the era of HAART: Analysis of 100 consecutive patients evaluated at a tertiary eye care center in IndiaOphthalmic Epidemiol200815426427118780260
   PubMed Web of Science ®Google Scholar
• BiswasJMadhavanHNGeorgeAEOcular lesions associated with HIV infection in India: A series of 100 consecutive patients evaluated at a referral centerAm J Ophthalmol200012991510653406
   PubMed Web of Science ®Google Scholar
• BiswasPNSahaBGhoshSOphthalmic manifestations in people living with HIV attending a tertiary care centre of Eastern IndiaJ Indian Med Assoc200810629229418839634
   PubMedGoogle Scholar
• NkomazanaOTshitswanaDOcular complications of HIV infection in sub-Sahara AfricaCurr HIV/AIDS Rep2008512012518627660
   PubMedGoogle Scholar
• NwosuNNHIV/AIDS in ophthalmic patients: The Guinness Eye Centre Onitsha experienceNiger Postgrad Med J200815242718408779
   PubMedGoogle Scholar
• T/GiorgisAMelkaGMariamAOphthalmic manifestation of aids in Armed Forces General Teaching Hospital, Addis AbabaEthiop Med J20074532733418326342
   PubMedGoogle Scholar
• OsahonAlOnunuANOcular disorders in patients infected with the human immunodeficiency virus at the University of Benin Teaching Hospital, Benin City, NigeriaNiger J Clin Pract200710428328618293635
   PubMedGoogle Scholar
• ManosuthiWChaovavanichATansuphaswakifulSIncidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited settingJ Infect20075546446917714788
   PubMed Web of Science ®Google Scholar
• ShafranSDSingerJZarownyDPA comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: Rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study GroupN Engl J Med19963353773838676931
   PubMed Web of Science ®Google Scholar
• NicholsCWMycobacterium avium complex infection, rifabutin, and uveitis – is there a connection?Clin Infect Dis199622S43S478785256
   PubMed Web of Science ®Google Scholar
• CochereauIMlika-CabanneNGodinaudPAIDS related eye disease in Burundi, AfricaBr J Ophthalmol19998333934210365044
   PubMed Web of Science ®Google Scholar
• WengTNVersacePOcular association of HIV infection in the era of highly active antiretroviral therapy and the global perspectiveClin Exp Ophthalmol200533317329
   Web of Science ®Google Scholar
• AusayakhunSWatananifornSNgamtiphakornSPrasitsilpJIntravitreal foscarnet for cytomegalovirus retinitis in patients with AIDSJ Med Assoc Thai20058810310715960227
   PubMedGoogle Scholar
• TeerawattananonKIewsakulSYenjitrCEconomic evaluation of treatment administration strategies of ganciclovir for cytomegalovirus retinitis in HIV/AIDS patients in Thailand: a simulation studyPharmacoeconomics20072541342817488139
   PubMed Web of Science ®Google Scholar
• ChiouSHLiuCYHsuWMOphthalmic findings in patients with acquired immunodeficiency syndromeJ Microbiol Immunol Infect200033454810806964
   PubMedGoogle Scholar
• DeCockKMLucasSBLucasSClinical research, prophylaxis, therapy, and care for HIV disease in AfricaAm J Public Health199383138513898214225
   PubMed Web of Science ®Google Scholar
• National AIDS Control Organization, Ministry of Health and Family Welfare, Government of IndiaProgramme implementation guidelines for phased scale up of access to antiretroviral therapy for people living with HIV/AIDSMumbai, IndiaNational AIDS Control Organization2004
   Google Scholar
• BraitsteinPBrinkhofMWDabisFMortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesLancet200636781782416530575
   PubMed Web of Science ®Google Scholar